Technical Analysis for MNOV - MediciNova, Inc.

Grade Last Price % Change Price Change
F 5.58 2.57% 0.14
MNOV closed up 2.57 percent on Friday, February 26, 2021, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical MNOV trend table...

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.00%
Oversold Stochastic Weakness 0.00%
Down 3 Days in a Row Weakness 2.57%
Down 4 Days in a Row Weakness 2.57%
Down 5 Days in a Row Weakness 2.57%
Oversold Stochastic Weakness 2.57%
200 DMA Resistance Bearish -0.89%
MACD Bearish Centerline Cross Bearish -0.89%
Down 3 Days in a Row Weakness -0.89%
Down 4 Days in a Row Weakness -0.89%
Older End-of-Day Signals for MNOV ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


MediciNova, Inc. Description

MediciNova, Inc., a development stage biopharmaceutical company, focuses on acquiring and developing small molecule therapeutics for the treatment of serious diseases for the United States market. The company's principal product candidates include MN-166, an ibudilast-based drug candidate, which is in Phase I and Phase II clinical trials for the treatment of drug dependence and pain; and MN-221, a ß2 -adrenergic receptor agonist that has completed Phase II clinical trials for the treatment of acute exacerbations of asthma. It also has other product candidates in the clinical development for the treatment of acute exacerbations of asthma, multiple sclerosis and other central nervous system disorders, bronchial asthma, interstitial cystitis, solid tumor cancers, generalized anxiety disorders/insomnia, preterm labor, urinary incontinence, and thrombotic disorders. MediciNova, Inc. was founded in 2000 and is headquartered in La Jolla, California.


Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Development Pain Medication Multiple Sclerosis Respiratory Therapy Nervous System Disorders Asthma Central Nervous System Disorders Serious Diseases Molecule Therapeutics Pulmonology Solid Tumor Cancers Insomnia Urinary Incontinence Treatment Of Serious Diseases Bronchial Asthma Interstitial Cystitis

Is MNOV a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 13.25
52 Week Low 2.79
Average Volume 215,794
200-Day Moving Average 5.73
50-Day Moving Average 5.83
20-Day Moving Average 6.04
10-Day Moving Average 5.82
Average True Range 0.24
ADX 21.09
+DI 16.14
-DI 28.23
Chandelier Exit (Long, 3 ATRs ) 6.03
Chandelier Exit (Short, 3 ATRs ) 6.17
Upper Bollinger Band 6.75
Lower Bollinger Band 5.33
Percent B (%b) 0.18
BandWidth 23.53
MACD Line -0.08
MACD Signal Line 0.01
MACD Histogram -0.0965
Fundamentals Value
Market Cap 250.7 Million
Num Shares 44.9 Million
EPS -0.37
Price-to-Earnings (P/E) Ratio -15.16
Price-to-Sales 0.00
Price-to-Book 3.62
PEG Ratio -0.94
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.95
Resistance 3 (R3) 5.95 5.84 5.89
Resistance 2 (R2) 5.84 5.74 5.83 5.87
Resistance 1 (R1) 5.71 5.69 5.77 5.70 5.85
Pivot Point 5.59 5.59 5.62 5.59 5.59
Support 1 (S1) 5.46 5.50 5.53 5.46 5.31
Support 2 (S2) 5.35 5.44 5.34 5.29
Support 3 (S3) 5.22 5.35 5.27
Support 4 (S4) 5.21